These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
866 related items for PubMed ID: 22914610
1. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations. Rollins-Raval M, Pillai R, Warita K, Mitsuhashi-Warita T, Mehta R, Boyiadzis M, Djokic M, Kant JA, Roth CG. Appl Immunohistochem Mol Morphol; 2013 May; 21(3):212-7. PubMed ID: 22914610 [Abstract] [Full Text] [Related]
4. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H. Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943 [Abstract] [Full Text] [Related]
5. Immunohistochemical detection of cytoplasmic nucleophosmin in formalin-fixed paraffin-embedded marrow trephine biopsies in acute myeloid leukaemia. Lit BM, Kwong YL, Wong KF. J Clin Pathol; 2016 May; 69(5):409-14. PubMed ID: 26500335 [Abstract] [Full Text] [Related]
6. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India. Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B. Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614 [Abstract] [Full Text] [Related]
7. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM. Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998 [Abstract] [Full Text] [Related]
8. FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia. Mukda E, Pintaraks K, Sawangpanich R, Wiangnon S, Pakakasama S. Asian Pac J Cancer Prev; 2011 Jan; 12(7):1827-31. PubMed ID: 22126574 [Abstract] [Full Text] [Related]
9. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia. Guo RJ, Atenafu EG, Schimmer AD, Minden MD, Chang H. Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150 [Abstract] [Full Text] [Related]
10. FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics. Rezaei N, Arandi N, Valibeigi B, Haghpanah S, Khansalar M, Ramzi M. Turk J Haematol; 2017 Dec 01; 34(4):300-306. PubMed ID: 28294102 [Abstract] [Full Text] [Related]
11. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A, Gillis D, Lewis I. J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508 [Abstract] [Full Text] [Related]
12. [Correlation of NPM1, FLT3-ITD mutations with leukocyte count and myeloblasts percentage in AML patients with normal karyotype]. Su L, Li W, Cui JW, Tan YH, Yang Y, Liu XL, Yu P, Hu RP, Wang LL, Gao SJ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun 27; 21(3):571-5. PubMed ID: 23815900 [Abstract] [Full Text] [Related]
13. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K. Ann Hematol; 2012 Jan 27; 91(1):9-18. PubMed ID: 21744003 [Abstract] [Full Text] [Related]
14. Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia. Dalal BI, Mansoor S, Manna M, Pi S, Sauro GD, Hogge DE. Clin Lymphoma Myeloma Leuk; 2012 Aug 27; 12(4):274-9. PubMed ID: 22481022 [Abstract] [Full Text] [Related]
15. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia. Scholl S, Theuer C, Scheble V, Kunert C, Heller A, Mügge LO, Fricke HJ, Höffken K, Wedding U. Eur J Haematol; 2008 Mar 27; 80(3):208-15. PubMed ID: 18081718 [Abstract] [Full Text] [Related]
16. NPM1, FLT3-ITD, CEBPA, and c-kit mutations in 312 Chinese patients with de novo acute myeloid leukemia. Su L, Gao SJ, Li W, Tan YH, Cui JW, Hu RP. Hematology; 2014 Sep 27; 19(6):324-8. PubMed ID: 24164801 [Abstract] [Full Text] [Related]
17. [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis]. Li L, Lyu XD, Mi RH, Ding J, Chen L, Wang Q, Yin QS, Hu JY, Fan RH, Wei XD. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun 27; 21(3):601-6. PubMed ID: 23815906 [Abstract] [Full Text] [Related]
18. Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML. Guardia RD, González-Silva L, López-Millán B, Rodríguez-Sevilla JJ, Baroni ML, Bueno C, Anguita E, Vives S, Palomo L, Lapillonne H, Varela I, Menendez P. Genes (Basel); 2020 Jan 09; 11(1):. PubMed ID: 31936647 [Abstract] [Full Text] [Related]
19. The surface molecular signature of leukemic cells is associated with NPM1 mutations and FLT3 -ITD in patients with de novo acute myeloid leukemia. Su L, Gao SJ, Li W, Tan YH, Cui JW, Han W. Acta Haematol; 2014 Jan 09; 131(3):148-52. PubMed ID: 24192815 [Abstract] [Full Text] [Related]
20. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients. El Gammal MM, Ebid GT, Madney YM, Abo-Elazm OM, Kelany AK, Torra OS, Radich JP. Clin Lymphoma Myeloma Leuk; 2019 Jun 09; 19(6):e281-e290. PubMed ID: 30926392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]